References
- MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev200456218522915169927
- PollakisGGoormaghtighERuysschaertJMRole of the quinine structure in the mitochondrial damage induced by antitumor anthracyclines. Comparison of adriamycin and 5-iminodaunorubicinFEBS Lett198315522672726852236
- SingalPKIliskovicNDoxorubicin-induced cardiomyopathyN Engl J Med1998339139009059744975
- SingalPKIliskovicNLiTKumarDAdriamycin cardiomyopathy: pathophysiology and preventionFASEB J199711129319369337145
- KongSDZhangWZLeeJHMagnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug releaseNano Lett20101050885092
- OlariuCIYiuHHPBouffierLMultifunctional Fe3O4 nanoparticles for targeted bi-modal imaging of pancreatic cancerJ Mater Chem2011211265012659
- ArrueboMFernández-PachecoRIbarraMRSantamaríaJMagnetic nanoparticles for drug deliveryNano today2007232232
- AlexiouCArnoldWKleinRJLocoregional cancer treatment with magnetic drug targetingCancer Res200060236641664811118047
- BabincovaMAltanerovaVAltanerCCicmanecPBabinecPIn vivo heating of magnetic nanoparticles in alternating magnetic fieldMed Phys20043182219222115377087
- BruléSLevyMWilhelmCDoxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapyAdv Mater201123678779021287643
- MikhaylovGMikacUMagaevaAAFerri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironmentNat Nanotechnol20116959460221822252
- GaihreBKhilbMSLeeDRKimHYGelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release studyInt J Pharm20093651–218018918790029
- YuJMXieXZhengMFabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicinInt J Nanomedicine201275079509023049255
- El-GamelNEWortmannLArroubKMathurSSiO2@Fe2O3 core-shell nanoparticles for covalent immobilization and release of sparfloxacin drugChem Commun (Camb)2011476100761007821829847
- AllenTMCullisPRDrug delivery systems: entering the nainstreamScience200430356651818182215031496
- PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
- PearceTRShroffKKokkoliEPeptide targeted lipid nanoparticles for anticancer drug deliveryAdv Mater2012242838033822371022674563
- ParkJWHongKKirpotinDBAnti-HER2 immunoliposomes: enhanced efficacy attributable to targeted deliveryClin Cancer Res2002841172118111948130
- YuMKParkJJeongYYMoonWKJonSIntegrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug deliveryNanotechnology2010214141510220852354
- ToublanFJJBoppartSSuslickKSTumor targeting by surface-modified protein microspheresJ Am Chem Soc2006128113472347316536492
- Indira ChandranVMatesicLLockeJMSkropetaDRansonMVineKLAnti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptorCancer Lett2012316215115622115965
- DanielsTRDelgadoTRodriguezJAHelgueraGPenichetMLThe transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancerClin Immunol2006121214415816904380
- DanielsTRDelgadoTHelgueraGPenichetMLThe transferrin receptor part II: targeted delivery of therapeutic agents into cancer cellsClin Immunol2006121215917616920030
- PengJLWuSZhaoXPDownregulation of transferrin receptor surface expression by intracellular antibodyBiochem Biophys Res Commun2007354486487117266924
- KangYSRisbudSRaboltJFStroevePSynthesis and characterization of nanometer-size Fe3O4 and γ-Fe2O3 particlesChem Mater19968922092211
- LiuXMaZXingJLiuHPreparation and characterization of amino-silane modified superparamagnetic silica nanospheresJ Magn Magn Mater20042701–216
- GuoLHuangJZhangXLiYZhengLBacterial magnetic nanoparticle as a drug carrierJ Mater Chem20081859935997
- BlissCThe calculation of the dose-mortality curveAnn Appl Biol193522134167
- CiofaniGDel TurcoSGenchiGGD’AlessandroDBastaGMattoliVTransferrin-conjugated boron nitride nanotubes: protein grafting, characterization, and interaction with human endothelial cellsInt J Pharm20124361–244445322732669
- DuWXuZNystromAMZhangKLeonardJRWooleyKL19F- and fluorescently labeled micelles as nanoscopic assemblies for chemotherapeutic deliveryBioconjug Chem200819122492249819049473
- GuoSLiDZhangLLiJWangEMonodisperse mesoporous super-paramagnetic single-crystal magnetite nanoparticles for drug deliveryBiomaterials20093011881188919135248
- HuYXieJTongYWWangCHEffect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cellsJ Control Release2007118171717241684
- MezaMaryChapter 22: Application of magnetic particles in immunoassaysHafeliUSchuttWZborowskiMScientific and Clinical Applications of Magnetic CarriersNew YorkPlenum1997303310
- XuXDengCGaoMYuWYangPZhangXSynthesis of magnetic microspheres with immobilized metal ions for enrichment and direct determination of phosphopeptides by matrix-assisted laser desorption ionization mass spectrometryAdv Mater2006182432893293
- SahuSKMaitiSPramanikAGhoshSKPramanikPControlling the thickness of polymeric shell on magnetic nanoparticles loaded with doxorubicin for targeted delivery and MRI contrast agentCarbohydr Polym201287425932604